Literature DB >> 28448658

Understanding Neuroendocrine Tumors-A NET Gain.

Pamela L Kunz1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28448658     DOI： 10.1001/jamaoncol.2017.0575

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  6 in total

1.  Costs of Cancer Care for Elderly Patients with Neuroendocrine Tumors.

Authors:  Chan Shen; Arvind Dasari; Dian Gu; Yiyi Chu; Shouhao Zhou; Ying Xu; Daniel Halperin; Shuangshuang Fu; James C Yao; Ya-Chen Tina Shih
Journal:  Pharmacoeconomics       Date:  2018-08       Impact factor: 4.981

2.  Patterns of Symptoms Burden in Neuroendocrine Tumors: A Population-Based Analysis of Prospective Patient-Reported Outcomes.

Authors:  Julie Hallet; Laura E Davis; Alyson L Mahar; Calvin H L Law; Elie Isenberg-Grzeda; Lev D Bubis; Simron Singh; Sten Myrehaug; Haoyu Zhao; Kaitlyn Beyfuss; Lesley Moody; Natalie G Coburn
Journal:  Oncologist       Date:  2019-07-03

Review 3.  Extent of Lymph Node Dissection for Small Bowel Neuroendocrine Tumors.

Authors:  Julie Hallet; Calvin Law
Journal:  World J Surg       Date:  2020-07-31       Impact factor: 3.352

4.  PAM staining intensity of primary neuroendocrine neoplasms is a potential prognostic biomarker.

Authors:  Timothy M Horton; Vandana Sundaram; Christine Hye-Jin Lee; Kathleen Hornbacker; Aidan Van Vleck; Kaisha N Benjamin; Allison Zemek; Teri A Longacre; Pamela L Kunz; Justin P Annes
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

5.  Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysis.

Authors:  Sheila D Rustgi; Aaron Oh; Jeong Yun Yang; Dasol Kang; Edward Wolin; Chung Y Kong; Chin Hur; Michelle K Kim
Journal:  BMC Cancer       Date:  2021-05-24       Impact factor: 4.430

6.  Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database.

Authors:  Ziteng Zhang; Xin Zhao; Zhiyan Li; Youchun Wu; Yao Liu; Zhiwei Li; Guobao Li
Journal:  BMC Cancer       Date:  2021-05-18       Impact factor: 4.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.